T1	Condition 0 15	Type 1 diabetes
T2	Condition 23 48	peripheral artery disease
T3	Measurement 50 63	Liver enzymes
T4	Value 64 118	equal or more than 1.5 times the upper limit of normal
R1	Has_value Arg1:T3 Arg2:T4	
T5	Measurement 142 146	NYHA
T6	Value 147 162	class III or IV
R2	Has_value Arg1:T5 Arg2:T6	
T7	Condition 120 141	Chronic heart failure
R3	AND Arg1:T7 Arg2:T5	
T8	Procedure 172 185	haemodialysis
T9	Procedure 189 208	peritoneal dialysis
*	OR T9 T8
T10	Temporal 164 171	Current
T11	Scope 172 208	haemodialysis or peritoneal dialysis
R4	Has_temporal Arg1:T11 Arg2:T10	
T12	Condition 210 233	End stage liver disease
T13	Condition 255 276	chronic liver disease
T14	Condition 246 251;263 276	acute liver disease
*	OR T14 T13
T15	Temporal 281 287	recent
T16	Condition 321 328	ascites
T17	Condition 330 344	encephalopathy
T18	Condition 346 363	variceal bleeding
T19	Measurement 365 374	bilirubin
T20	Value 375 406	equal or greater than 2.0 mg/dL
R5	Has_value Arg1:T19 Arg2:T20	
T21	Measurement 408 415	albumin
T22	Value 416 444	equal or less than 3.5 g/ dL
R6	Has_value Arg1:T21 Arg2:T22	
T23	Measurement 446 462	prothrombin time
T24	Value 463 492	greater or equal to 4 seconds
R7	Has_value Arg1:T23 Arg2:T24	
T25	Measurement 494 497	INR
T26	Value 498 526	greater than or equal to 1.7
R8	Has_value Arg1:T25 Arg2:T26	
T27	Temporal 530 535	prior
T28	Procedure 536 552	liver transplant
R9	Has_temporal Arg1:T28 Arg2:T27	
*	OR T25 T23 T28 T21 T19 T18 T17 T16
T29	Scope 321 552	ascites, encephalopathy, variceal bleeding, bilirubin equal or greater than 2.0 mg/dL, albumin equal or less than 3.5 g/ dL, prothrombin time greater or equal to 4 seconds, INR greater than or equal to 1.7 or prior liver transplant
R10	Has_temporal Arg1:T29 Arg2:T15	
T30	Scope 246 552	acute or chronic liver disease and recent history of one of the following: ascites, encephalopathy, variceal bleeding, bilirubin equal or greater than 2.0 mg/dL, albumin equal or less than 3.5 g/ dL, prothrombin time greater or equal to 4 seconds, INR greater than or equal to 1.7 or prior liver transplant
R11	Subsumes Arg1:T12 Arg2:T30	
T31	Condition 573 589	hypersensitivity
T32	Drug 593 607	trial products
T33	Drug 611 627	related products
*	OR T33 T32
T34	Scope 593 627	trial products or related products
T35	Mood 563 572	suspected
T36	Mood 554 559	Known
*	OR T35 T36
T37	Scope 554 572	Known or suspected
R12	Has_scope Arg1:T31 Arg2:T37	
R13	Has_scope Arg1:T31 Arg2:T34	
T38	Pregnancy_considerations 629 809	Female of child-bearing potential who is pregnant, breast-feeding or intends to become pregnant or is not using adequate contraceptive methods as required by law or local practice.
T39	Non-query-able 811 915	Expected simultaneous participation in any other clinical trial of an investigational medicinal product.
T40	Non-query-able 917 1001	Receipt of any investigational medicinal product within 30 days before randomization
T41	Condition 1045 1064	malignant neoplasms
T42	Temporal 1003 1010	Current
T43	Temporal 1014 1018	past
T44	Temporal 1020 1043	within the last 5 years
R14	Subsumes Arg1:T43 Arg2:T44	
*	OR T43 T42
T45	Scope 1003 1044	Current or past (within the last 5 years)
R15	Has_scope Arg1:T41 Arg2:T45	
T46	Condition 1073 1083;1107 1116	basal cell carcinoma
T47	Condition 1088 1116	squamous cell skin carcinoma
*	OR T46 T47
T48	Negation 1066 1072	except
T49	Scope 1073 1116	basal cell and squamous cell skin carcinoma
R16	Has_negation Arg1:T49 Arg2:T48	
R17	Has_scope Arg1:T41 Arg2:T49	
T50	Post-eligibility 1119 1250	Any condition that in the investigator's opinion would make the subject unable to adhere to the trial visit schedule and procedures
T51	Non-query-able 1252 1296	Known history of non-compliance to treatment
